Pfizer and Hisun sign China generics deal

September 13, 2012
Manufacturing and Production, Sales and Marketing China, Pfizer, branded generics, emerging markets, generics

Pfizer has unveiled a new joint venture with with China’s Zhejiang Hisun Pharmaceuticals. It is one of the first joint …

db3

The ex-CEO’s Job Blog – part 2

September 13, 2012
Sales and Marketing Jobs, careers, interviews, the ex-CEO's job blog

 Would you believe everything a used car salesman tells you? Of course not. So why do so many people accept …

Sanofi image

Setback for Sanofi dengue vaccine

September 13, 2012
Research and Development, Sales and Marketing Dengue fever, Sanofi, Sanofi Pasteur, Vaccine

Sanofi Pasteur’s vaccine for dengue fever has failed to show protection against a key serotype of the potentially fatal illness. …

Hospitals on ‘brink of collapse’, warn doctors

September 13, 2012
NHS, NHS reform, NHS reforms, QIPP, Sir John Oldham

Hospitals across the UK are struggling to cope with emergency admissions, and a doctors’ group has warned that patient safety …

Genzyme

Genzyme MS drug approved in US

September 13, 2012
Medical Communications Aubagio, Genzyme, Rebif, Sanofi, Tysabri, gilenya, multiple sclerosis

US regulators have given the green light for Genzyme’s Aubagio to treat patients with relapsing forms of multiple sclerosis (MS). …

GPs can access patient records via tablet devices

September 12, 2012
Medical Communications Digital Blog, GPs, NHS, ipad

The first ever service allowing GPs to access and update their patient records using an iPad or other tablet device …

The ABPI has welcomed the announcement

Pharma thumbs-up for government innovation centre

September 12, 2012
Research and Development, Sales and Marketing ABPI, synthetic biology

The announcement of a new innovation and knowledge centre for synthetic biology has been welcomed by pharma groups.The new centre is part …

The RNAi therapeutic mechnism

New frontiers in drug discovery

September 11, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing RNA, drug discovery, therapeutic

Despite the success of small molecule and biologic drugs such as monoclonal antibodies, there remain many areas of unmet medical …

dr_brett_haumann

Circassia appoints GSK’s Dr Brett Haumann

September 11, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brett Haumann, Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Brett Haumann as chief medical officer. Haumann joins allergy-focussed Circassia …

Merck image

Merck releases new Phase III insomnia data

September 11, 2012
Research and Development, Sales and Marketing Merck, insomnia, suvorexant

Merck says it is on course to file its investigational insomnia drug suvorexant in the US by the end of …

Patheon image

Patheon offloads clinical packaging ops

September 11, 2012
Manufacturing and Production Bellwyck, Ontario, Patheon

Patheon has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions as it continues …

Takeda HQ image

Takeda opens Russian manufacturing facility

September 11, 2012
Manufacturing and Production Actovegin, Nycomed, Russia, Takeda

Takeda Pharmaceutical has officially opened its new manufacturing facility in Yaroslavl, Russia, and expects it to be operating at full …

Rock appoints new associate director

September 11, 2012
Business Services, Medical Communications, Sales and Marketing Laura Patel, Rock Medical Communications

ROCK medical communications has appointed Laura Patel as associate director. Patel has considerable experience in managing key medical education programmes, …

MedImmune

MedImmune signs China deal

September 11, 2012
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis

MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …

screen_shot_2012-09-10_at_10

Ex-Pfizer head joins Red Door as International director

September 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Thomas, Pfizer, Red Door

Andrew Thomas the strategic communications lead for Pfizer’s primary care medicines across Europe and Canada joins Red Door Communications in …

lilly corporate hq image

Lilly suffers late-stage cancer blow

September 10, 2012
Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology

Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …

merck kgaa image

Merck KGaA licences new cancer candidate

September 10, 2012
Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology

Merck KGaA has signed a worldwide licence agreement with Danish company Symphogen which could expand its portfolio of drugs targeting …

Kantar appoints Graeme Jacombs head of APMEA region

September 7, 2012
Sales and Marketing Kantar Health

Consultancy and market research firm Kantar Health has promoted Graeme Jacombs to Managing Director of the Asia Pacific, Middle East …

Boehringer signs diabetes research deal

September 7, 2012
Sales and Marketing Boehringer, diabetes, obesity

Boehringer Ingelheim has signed a four-year research agreement with a top Swiss university to look at the underlying causes of …

Novartis to file for new Lucentis indication

September 7, 2012
Lucentis, Novartis, macular edema, macular oedema, ophthamology

Novartis is set to file eye treatment Lucentis for a new indication. The firm will submit Lucentis (ranibizumab) to the …

The Gateway to Local Adoption Series

Latest content